Young, P.; Elghawy, O.; Mock, J.; Wynter, E.; Gentzler, R.D.; Martin, L.W.; Novicoff, W.; Hall, R.
Impact of Opioid Use on Duration of Therapy and Overall Survival for Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Curr. Oncol. 2024, 31, 260-273.
https://doi.org/10.3390/curroncol31010017
AMA Style
Young P, Elghawy O, Mock J, Wynter E, Gentzler RD, Martin LW, Novicoff W, Hall R.
Impact of Opioid Use on Duration of Therapy and Overall Survival for Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Current Oncology. 2024; 31(1):260-273.
https://doi.org/10.3390/curroncol31010017
Chicago/Turabian Style
Young, Philip, Omar Elghawy, Joseph Mock, Emmett Wynter, Ryan D. Gentzler, Linda W. Martin, Wendy Novicoff, and Richard Hall.
2024. "Impact of Opioid Use on Duration of Therapy and Overall Survival for Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors" Current Oncology 31, no. 1: 260-273.
https://doi.org/10.3390/curroncol31010017
APA Style
Young, P., Elghawy, O., Mock, J., Wynter, E., Gentzler, R. D., Martin, L. W., Novicoff, W., & Hall, R.
(2024). Impact of Opioid Use on Duration of Therapy and Overall Survival for Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Current Oncology, 31(1), 260-273.
https://doi.org/10.3390/curroncol31010017
